Acquired hemophilia A (AHA) is a rare bleeding disorder caused by autoantibodies to coagulation factor VIII (FVIII) leading to potentially severe bleeding diathesis that carries a high rate of morbidity and mortality. It should be suspected in patients with unexplained prolonged aPTT, normal PT and acute abnormal bleedings without personal or familiar history of congenital bleeding disorders. Continue reading
